Aleksandra Pawska

Mrs. Aleksandra Pawska

Department of Inorganic and Analytical Chemistry, Poznan University of Medical Sciences, Poznań, Wielkopolskie, Poland
+1
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 June 2025 in Molecules
Verified
Journal Article
Open access
PDF file
MMMaciej Michalak
Maciej Michalak
JSJakub Szymczyk
Jakub Szymczyk
Aleksandra PawskaAleksandra Pawska
Aleksandra Pawska
MWMarcin Wysocki
Marcin Wysocki
DJDominika Janiak
Dominika Janiak
Lukasz SobottaLukasz Sobotta
Lukasz Sobotta
Photodynamic therapy (PDT) is a non-invasive therapeutic method with over a century of medical use, especially in dermatology, ophthalmology, dentistry, and, notably, cancer treatment. With an increasing number of clinical trials, there is growing demand for innovation in PDT. Despite being a promising treatment for cancer and bacterial infections, PDT faces limitations such as poor water solubility of many photosensitizers (PS), limited light penetration, off-target accumulation, and tumor hypoxia. This review focuses on chlorins—well-established macrocyclic PSs known for their strong activity and clinical relevance. We discuss how nanotechnology addresses PDT’s limitations and enhances therapeutic outcomes. Nanocarriers like lipid-based (liposomes, micelles), polymer-based (cellulose, chitosan, silk fibroin, polyethyleneimine, PLGA), and carbon-based ones (graphene oxide, quantum dots, MOFs), and nanospheres are promising platforms that improve chlorin performance and reduce side effects. This review also explores their use in Antimicrobial Photodynamic Therapy (aPDT) against multidrug-resistant bacteria and in oncology. Recent in vivo studies demonstrate encouraging results in preclinical models using nanocarrier-enhanced chlorins, though clinical application remains limited.

17 July 2026 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Aleksandra PawskaAleksandra Pawska
Aleksandra Pawska
Aleksey E. KuznetsovAleksey E. Kuznetsov
Aleksey E. Kuznetsov
MSMarianna Szczepaniak
Marianna Szczepaniak
DZDaniel Ziental
Daniel Ziental
EGEmre Güzel
Emre Güzel
Lukasz SobottaLukasz Sobotta
Lukasz Sobotta
Background/Objectives: An evaluation of the sensitizing properties of chloroindium(III) phthalocyanine complex (InPc) bearing 4-sulfonylphenoxy groups was performed. Methods: The ability to form singlet oxygen under light exposure was assessed, and the quantum yield ΦΔ was calculated to be 0.82 ± 0.04. Under ultrasound exposure of the sensitizer (1 MHz, 3 W, 40% duty cycle), significant 1,3-diphenylisobenzofuran decomposition was observed. Results: Moreover, the macrocycle was assigned to be a moderate–high photo- and sonostable sensitizer. Density functional theory studies supported experimental results, suggesting the InPc to be a good photochemical agent. From the global reactivity parameters analysis, it can be suggested that InPc would interact easily with electron-excess species, such as various free radicals, in the solution phase, and should also be able to interact with electrophilic species. Conclusions: Studied InPc revealed high photodynamic antimicrobial activity and reached >4 log10 reduction in microbial growth against methicillin-resistant Staphylococcus aureus, and 4.08 ± 0.29 log10 against Candida albicans resistant to fluconazole (for dosimetry of 100 μM and 50 J/cm2). Interestingly, the photosensitizer studied was inactive against extended-spectrum β-lactamase-producing Escherichia coli.